Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Intrinsic antifungal activity of curli nanofibers expands the design space for programmable antimicrobial biomaterials

Created on 20 Aug 2026

Authors

Burns, N., Kurowski, A., Hammad, H. M., Ross, B., Bryant, M., Duraj-Thatte, A. M.

Abstract

The rise of antifungal resistance and limited antifungal drug classes creates an urgent need for biomaterials with localized, programmable activity. Here, we engineered curli nanofibers displaying the antifungal peptide heliomicin and unexpectedly discovered that wild-type CsgA itself exhibits intrinsic antifungal activity against Candida albicans, reducing fungal viability by approximately 2 log units. Heliomicin fusion enhanced this activity to a 3.5-log fungicidal reduction while preserving nanofiber self-assembly, hydrogel formation, mechanical properties, and 3D printability. Mechanistic analyses linked enhanced activity to membrane disruption and expansion of the cationic surface of CsgA. Heliomicin-CsgA hydrogels further reduced fungal burden and suppressed hyphal development in an ex vivo porcine skin infection model. These findings reveal that extracellular protein nanofibers can harbor intrinsic biological activities that can be uncovered and enhanced through protein engineering, establishing a strategy for developing intrinsically bioactive, programmable biomaterials for localized therapeutic applications against fungal pathogens and potentially other microbial infections.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 20 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement